The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation models. Pfizer and Boltz have announced a collaboration aimed at expanding the ...
Pfizer $PFE has licensed the AI drug discovery platform of startup Chai Discovery, giving the pharmaceutical company access to generative AI models designed to ...
Boltz has raised $28 million in fresh funding while entering a strategic partnership with Pfizer that underscores the accelerating push by major drugmakers to embed artificial intelligence deeper into ...
Pfizer scientists will leverage Chai Discovery’s AI platform - including Chai-3, its most advanced model - alongside custom software, to help accelerate drug discovery research Chai Discovery, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results